ClinicalTrials.Veeva

Menu

Inflammation and Cellular Immunity in Vaginal Tissue in Patients With Pelvic Organ Prolapse

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Pelvic Organ Prolapse

Treatments

Procedure: Colporrhaphy
Procedure: Hysterectomy

Study type

Observational

Funder types

Other

Identifiers

NCT03748693
HYMC-0073-18

Details and patient eligibility

About

The aim of this study is to investigate the inflammatory and maturation processes of immature myeloid cells (IMC) in the vaginal tissue in women with advanced pelvic organ prolapse (POP) (stage III-IV) and in normal non-POP controls.

We hypothesize that the processes contributing to POP may be related to immune response and changes in myeloid cell populations and the cytokine environment.

Enrollment

20 estimated patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with POP undergoing colporrhaphy
  • Women undergoing hysterectomy

Exclusion criteria

  • Autoimmune and connective tissue disorders
  • Cancer in genital tract

Trial design

20 participants in 2 patient groups

POP Group
Description:
Women with POP undergoing surgery in our OB/GYN department.
Treatment:
Procedure: Colporrhaphy
Non-POP Group
Description:
Women undergoing hysterectomy for other indications.
Treatment:
Procedure: Hysterectomy

Trial contacts and locations

0

Loading...

Central trial contact

Mariana Ordonez, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems